China: How to strategise and win in the world's fastest changing healthcare market
In this paper, our experts Marc Yates, Pei Li Teh and Brett Gardiner discuss the China healthcare reforms which affect pharma and propose how to build the market understanding required to launch a brand effectively in this exciting region.
With a population of 1.4 billion people China has always been an attractive prize to the pharmaceutical industry. However, China has historically been a tough market to crack and few multinational companies have seen a good return on their investment. But in 2019, the 70th anniversary of the communist party’s victory, the outlook has changed completely and now pharma is rushing to leverage the many opportunities that China offers.
Innovation, sustainability and prosperity: Japan’s healthcare vision for the future
By Callum McCulloch and Marc Yates
In 2015, the Japanese government appointed an advisory panel of young experts to lay out its vision of healthcare in the country for 2035. This vision is a healthcare system that delivers unrivalled health outcomes, provides secure and responsive care for all in society, is sustainable, and contributes to prosperity in the nation and around the world.
Yet, how achievable is this ideal, and how does the government plan to realize its vision? What is clear is that it will require a paradigm shift – a move from quantity to quality of care and from inputs to value, on care rather than cure, on autonomy over regulation, on national integration rather than fragmentation.
Webcast: Going for growth - Maximising your return on insights in Emerging Markets
Healthcare market research in emerging markets is still evolving, so finding the insights you require and then maximising the return on those insights can be challenging. Download this complimentary webcast in which Emerging Markets Directors Marc Yates and Rachel Howard will provide you with the critical success factors to ensure actionable primary research in emerging markets.
South Korea: The next global player?
In this paper, we will explore some of the key trends and outlooks for South Korea in more detail, including what lies behind its presence at the extremes of two conflicting global health indicators: longest life expectancy and highest suicide rates.
Over the past two decades South Korea has experienced rapid economic growth. Low unemployment, rising incomes and increased health insurance coverage have all contributed to the development of a robust healthcare sector and catalysed pharmaceutical sales. South Korea is currently the 13th largest pharmaceutical market in the world and the third largest in Asia, with predicted compound annual growth rate (CAGR) of 2.4%. increasing from US$18.6 billion in 2016 to US$20.4 billion by 2020.
How to conduct effective market research in emerging markets
Pharmaceutical market research is still evolving in many emerging markets and so finding the insights you require can be a challenge.
In this webinar, using examples from a wide range of emerging markets, we will explain the important cultural, methodological and quality considerations and provide you with the core critical success factors to guaranteeing effective primary research in emerging markets.